Orange Book product · Brand (NDA)
PHENYLEPHRINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE
PHENYLEPHRINE HYDROCHLORIDE
At a glance
May 30, 2025
Approved
Brand (NDA)
Application
Not listed
TE code
1
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 30, 2025
1 yr 1 mo ago
Today
Patent 12564561 expires
Listed drug product patent expiration.
Aug 08, 2044
in 18 yr 5 mo
Pharmaceutical detail
Active ingredient
PHENYLEPHRINE HYDROCHLORIDE
Strength
20MG/250ML (0.08MG/ML)
Dosage form
SOLUTION
Route
INTRAVENOUS
TE code
Not listed
Application
NDA 216830
Product number
001
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
Yes
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2023IMMPHENTIVBrand (NDA)
NDA 203826 · HIKMA
- 2019BIORPHENBrand (NDA)
NDA 212909 · DR REDDYS LABS SA
- 2015PHENYLEPHRINE HYDROCHLORIDEBrand (NDA)
NDA 207926 · ALCON
- 2014VAZCULEPBrand (NDA)
NDA 204300 · EXELA PHARMA
- 2013PHENYLEPHRINE HYDROCHLORIDEBrand (NDA)
NDA 203510 · PARAGON BIOTECK
- 2026PHENYLEPHRINE HYDROCHLORIDEGeneric (ANDA)
ANDA 217032 · BAXTER HLTHCARE CORP
- 2025PHENYLEPHRINE HYDROCHLORIDEGeneric (ANDA)
ANDA 215617 · SOMERSET THERAPS LLC
- 2024PHENYLEPHRINE HYDROCHLORIDEGeneric (ANDA)
ANDA 218129 · GLAND
- 2024PHENYLEPHRINE HYDROCHLORIDEGeneric (ANDA)
ANDA 215183 · CAPLIN
- 2024PHENYLEPHRINE HYDROCHLORIDEGeneric (ANDA)
ANDA 218110 · ASPIRO
- 2024PHENYLEPHRINE HYDROCHLORIDEGeneric (ANDA)
ANDA 218412 · HAINAN POLY
- 2023PHENYLEPHRINE HYDROCHLORIDEGeneric (ANDA)
ANDA 217521 · BE PHARMS
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 12564561 | Aug 08, 2044 | in 18 yr 5 mo | Product |

